Flucytosine labels and packages: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
Line 6: Line 6:
|[[File:250mgAncobon.JPG|600px|thumb]]
|[[File:250mgAncobon.JPG|600px|thumb]]
|}
|}


{|
{|

Latest revision as of 19:48, 5 January 2014

Flucytosine
ANCOBON® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]


[1]

References

  1. "ANCOBON (FLUCYTOSINE) CAPSULE [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]".

Adapted from the FDA Package Insert.